Covid-19: Regeneron treatment approved, 12 million cases in the U.S

 Covid-19: Regeneron treatment approved, 12 million cases in the U.S

Faced with a galloping epidemic of Covid-19 which has contaminated 12 million people on its territory, the United States has urgently authorised an innovative treatment from the Regeneron firm, which has already been tried on President Donald Trump.

The United States is by far the country most bereaved in the world by the coronavirus with 255,800 deaths. The epidemic is progressing out of control and the number of new daily cases is exploding (nearly 164,000 for the only day yesterday, Saturday, November 21, 2020) could now exceed 12 million sick, according to the Johns Hopkins University.

Faced with this scourge, the US Drug Agency (FDA) granted emergency child authorization on Saturday to a synthetic antibody cocktail from the biotech company Regeneron. This treatment is known to have been administered to Donald Trump, who had widely praised it after recovering from Covid-19 in October

Video. United States: Donald Trump declares immunity to Covid-19 and returns to combat

According to the FDA, REGEN-COV2 treatment, a combination of two antibodies manufactured in the laboratory, has been shown to reduce Covid-19-related hospitalizations or emergency room visits in customers with secondary diseases or “co-morbidities”

“Allowing these monoclonal antibody therapies could allow patients to avoid hospitalization and ease the burden on our health care system,” said FDA official Stephen Hahn

” Promising therapy”

Regeneron’s President, Leonard Schleifer, assured that this decisi

Learn More

Redak staff

Leave a Reply

Your email address will not be published.